Los Angeles - 
(NewMediaWire) - November 17, 2021 - The Schall Law Firm, a national shareholder rights litigation firm,
announces that it is investigating claims on behalf of investors of Ginkgo
Bioworks Holdings, Inc. (“Ginkgo” or “the
Company”) (NYSE: DNA) for violations of the securities laws.
The investigation focuses on whether the Company
issued false and/or misleading statements and/or failed to disclose information
pertinent to investors. Ginkgo is the subject of a report published by Scorpion
Capital on October 6, 2021. The report alleges that the Company is a “colossal
scam.” The report describes the Company as a “shell game” whose revenues are
highly dependent on related-party transactions. Scorpion Capital alleges that
the Company is a “Frankenstein mash-up of the worst frauds of the last 20
years.” Based on this news, Ginkgo shares fell as much as 20% in intraday
trading on the same day.
If you are a shareholder who
suffered a loss, click
here to participate.
We also encourage you to contact
Brian Schall of the Schall Law Firm, 2049
Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also
reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The class in this case has not
yet been certified, and until certification occurs, you are not represented by
an attorney. If you choose to take no action, you can remain an absent class
member.
The Schall Law Firm represents
investors around the world and specializes in securities class action lawsuits
and shareholder rights litigation.
This press release may be
considered Attorney Advertising in some jurisdictions under the applicable law
and rules of ethics.
CONTACT:
The Schall
Law Firm
Brian Schall, Esq.
310-301-3335
